Soleno has established a comprehensive support program, Soleno ONE™, to assist patients, caregivers and healthcare providers ...

Relate XR was founded as a collaboration between Oberlin and Nelson. The duo teamed up when Oberlin was looking for a partner ...

Sign up for Men's Journal's newsletter to get gear, fitness, and more deals delivered straight to your inbox.

Rilzabrutinib, an investigational oral BTK inhibitor, has received orphan drug designation from the FDA for treating warm autoimmune hemolytic an ...

This ongoing industry growth stems from the broad spectrum of use cases that have arisen for XT technology for clinicians and patients alike (displayed in the table below). These applications make use ...

The government recently announced a new batch of drugs — including blockbuster weight-loss treatment Wegovy and prostate ...

The United States Food and Drug Administration (US FDA) has approved VYKAT™ XR, a significant milestone as the first approved treatment for hyperphagia in Prader-Willi syndrome (PWS).

A new drug could change everything for children like seven-year-old daughter, Liliana, who has Prader-Willi syndrome, a rare ...

The FDA has approved Vykat XR (diazoxide choline) for the treatment of hyperphagia in adults and pediatric patients 4 years ...

As the Trump administration pushes to “Make America Healthy Again” and lays the groundwork for various reforms to American health care, it should set its sights on reforming the Food ...

1 VYKAT ™ XR is the first and only FDA-approved treatment for hyperphagia in individuals with PWS. PWS is a genetic disorder estimated to occur in approximately one in every 15,000 live births. This ...